Quick10K

⚲

NL Industries

Filings

10-Q	2020-09-30	Filed 2020-11-04
10-Q	2020-06-30	Filed 2020-08-05
10-Q	2020-03-31	Filed 2020-05-06
10-K	2019-12-31	Filed 2020-03-11
10-Q	2019-09-30	Filed 2019-11-07
10-Q	2019-06-30	Filed 2019-08-07
10-Q	2019-03-31	Filed 2019-05-09
10-K	2018-12-31	Filed 2019-03-11
10-Q	2018-09-30	Filed 2018-11-07
10-Q	2018-06-30	Filed 2018-08-07
10-Q	2018-03-31	Filed 2018-05-08
10-K	2017-12-31	Filed 2018-03-12
10-Q	2017-09-30	Filed 2017-11-08
10-Q	2017-06-30	Filed 2017-08-08
10-Q	2017-03-31	Filed 2017-05-08
10-K	2016-12-31	Filed 2017-03-10
10-Q	2016-09-30	Filed 2016-11-07
10-Q	2016-06-30	Filed 2016-08-05
10-Q	2016-03-31	Filed 2016-05-06
10-K	2015-12-31	Filed 2016-03-10
10-Q	2015-09-30	Filed 2015-11-06
10-Q	2015-06-30	Filed 2015-08-07
10-Q	2015-03-31	Filed 2015-05-08
10-K	2014-12-31	Filed 2015-03-12
10-Q	2014-09-30	Filed 2014-11-07
10-Q	2014-06-30	Filed 2014-08-07
10-Q	2014-03-31	Filed 2014-05-08
10-K	2013-12-31	Filed 2014-03-12
10-Q	2013-09-30	Filed 2013-11-06
10-Q	2013-06-30	Filed 2013-08-07
10-Q	2013-03-31	Filed 2013-05-08
10-K	2012-12-31	Filed 2013-03-12
10-Q	2012-09-30	Filed 2012-11-06
10-Q	2012-06-30	Filed 2012-08-09
10-Q	2012-03-31	Filed 2012-05-09
10-K	2011-12-31	Filed 2012-03-06
10-Q	2011-09-30	Filed 2011-11-03
10-Q	2011-06-30	Filed 2011-08-03
10-Q	2011-03-31	Filed 2011-05-04
10-K	2010-12-31	Filed 2011-03-07
10-Q	2010-09-30	Filed 2010-11-01
10-Q	2010-06-30	Filed 2010-08-03
10-Q	2010-03-31	Filed 2010-05-04
10-K	2009-12-31	Filed 2010-03-10

Reports

8-K	2020-11-04
8-K	2020-10-29
8-K	2020-08-05
8-K	2020-05-21
8-K	2020-05-06
8-K	2020-04-22
8-K	2020-03-13
8-K	2020-03-11
8-K	2020-02-19
8-K	2019-11-07
8-K	2019-09-03
8-K	2019-08-07
8-K	2019-07-24
8-K	2019-07-16
8-K	2019-05-16
8-K	2019-05-16
8-K	2019-05-09
8-K	2019-03-18
8-K	2019-03-08
8-K	2018-11-07
8-K	2018-08-07
8-K	2018-05-17
8-K	2018-05-08
8-K	2018-03-15
8-K	2018-03-12

NL Industries Financials

NL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546	323	0	0	0	0	-854
1 800 Flowers Com (FLWS)	944	42%	13.3	6%	665	336	1,266	534	37	75	1,001
10x Genomics (TXG)	4,805	75%	-490.3	-2%	573	151	61	46	-10	-9	4,357
12 Retech (RETC)	0	32%	-0.1	-1,385%	1	20	1	0	-15	-15	1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	34	0%	0.4	-5%	164	108	18	0	-8	-8	-3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	19	23	27	7	-3	-1	3
1895 Bancorp of Wisconsin (BCOW)	46,153		12,508.1	-0%	441	383	0	0	-0	4	46,142
1st Constitution Bancorp (FCCY)	165	0%	4.4	1%	1,343	1,204	0	0	14	33	144
1st Franklin Financial (FFC)	4		-0.6	7%	905	645	0	0	62	80	-46
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200		7.9	1%	6,691	5,858	0	0	70	136	1,073
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	2	0	0	-2	-2	0
21Vianet Group (VNET)	6,005			0%	11,151	5,788	0	0	0	0	3,344
22nd Century (XXII)	302	1%	-14.1	-36%	62	7	26	0	-22	-21	302
1Life Healthcare (ONEM)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	7	14	12	5	7	9	78	73	72	52	53	53	58	73	73	73	83	88	96	95	102	101	93	93	95	102	103	104	116	128	121	116	132	138
Accounts Receivable
Inventory	21	20	20	20	19	19	11	12	12	13	13	15	16	15	17	17	16	15	15	14	14	15	15	15	15	15	15	16	17	17	17	19	18	19
PP&E	181	169	170	171	467	491	522	503	508	524	87	87	88	89	89	90	91	92	92	94	94	94	95	95	96	96	97	97	98	95	96	96	96	96
Assets	709	757	761	759	2,116	2,036	2,027	1,860	1,742	1,674	686	560	534	540	501	482	435	370	349	348	354	380	385	396	457	481	552	575	591	570	547	561	591	555
Accounts Payable	8	6	8	7	7	8	5	4	4	6	3	5	5	6	6	5	10	5	5	5	4	5	5	5	5	5	4	4	4	6	5	4	4	5
Long-Term Debt	57	71	37	39	28	33	18	280	288	203	0
Liabilities	330	352	335	339	660	577	596	601	540	573	317	271	263	263	249	235	219	192	184	183	185	194	191	192	211	216	199	204	267	259	244	241	262	232
Stockholders' Equity	368	393	415	409	1,054	1,116	1,062	982	937	920	355	275	257	263	237	233	201	164	150	149	153	170	178	187	229	248	335	353	306	292	284	300	307	301


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	35	36	33	36	545	1,506	397	464	908	419	22	26	27	26	25	28	29	27	26	27	27	28	26	30	30	27	25	28	32	30	27	31	34	30
Cost of Revenue	25	27	25	26	534	1,496	391	458	900	412	16	18	18	18	17	19	20	18	18	19	19	19	17	20	20	19	18	19	21	20	20	22	23	20
Gross Profit	10	9	8	9	11	10	6	6	8	8	6	8	9	8	8	9	9	8	8	8	8	9	9	10	10	8	7	10	11	10	8	10	11	9
R&D
SG&A	6	6	6	7	7	6	-1	5	5	5	4	4	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5		5	5	5
Tax	1	12	1	9	8	3	0	0	0	0	0	1	0	4	0	1	-21	-4	-3	0	0	-1	-2	2	20	6	0	3	-2	0		3	1	-2
Net Income	17	28	20	21	64	35	21	-2	-14	-6	-33	4	6	14	5	10	-29	1	-6	-2	1	8	10	9	42	18	49	15	-42	-15	3	16	7	-1


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		2	24	-1	6	5	9	-2	5	5	8	1	6	16	1	1	12			0	7	10	10	2	8	5	3	2		9		2	17	-2
Cash Investing		-3	14	-1	14	-2	82	3	1	-0	-1	-1	-1	-1	-1	-0	-2			-1	-0	-11	-17	-2	-11	2	-2	-0		4		-6	-1	7
Cash Financing		9	-40	-5	-17	-1	-21	-7	-6	-24	-6	-0	-0	-0	-0